Literature DB >> 8195192

1-beta-D-Arabinofuranosylcytosine stimulates ceramide and diglyceride formation in HL-60 cells.

J C Strum1, G W Small, S B Pauig, L W Daniel.   

Abstract

The effect of 1-beta-D-arabinofuranosylcytosine (ara-C) on phospholipid metabolism was investigated in HL-60 cells. Treatment of cells with ara-C resulted in a time- and dose-dependent increase in the mass of ceramide and diglyceride. When cells were treated with 10 microM ara-C, an increase in the mass of ceramide and diglyceride was detectable at 5 min and reached a plateau at 30 min with a 2-fold increase compared to control cells. Treatment of cells with 10 microM ara-C resulted in the activation of neutral sphingomyelinase with a peak at 30 min that represented a 2-fold increase in specific activity. ara-C also increased expression of the transcription factor NF-kappa B which is related to the control of monocyte differentiation. These findings suggest that ara-C activates phospholipid hydrolytic pathways to generate second messengers that control gene expression and differentiation in the HL-60 cell line.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8195192

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  Transforming growth factor beta1 attenuates ceramide-induced CPP32/Yama activation and apoptosis in human leukaemic HL-60 cells.

Authors:  M L Kuo; C W Chen; S H Jee; S E Chuang; A L Cheng
Journal:  Biochem J       Date:  1997-11-01       Impact factor: 3.857

2.  Role for ceramide as an endogenous mediator of Fas-induced cytotoxicity.

Authors:  C G Tepper; S Jayadev; B Liu; A Bielawska; R Wolff; S Yonehara; Y A Hannun; M F Seldin
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-29       Impact factor: 11.205

3.  p53-dependent ceramide response to genotoxic stress.

Authors:  G S Dbaibo; M Y Pushkareva; R A Rachid; N Alter; M J Smyth; L M Obeid; Y A Hannun
Journal:  J Clin Invest       Date:  1998-07-15       Impact factor: 14.808

Review 4.  Interdiction of sphingolipid metabolism to improve standard cancer therapies.

Authors:  Thomas H Beckham; Joseph C Cheng; S Tucker Marrison; James S Norris; Xiang Liu
Journal:  Adv Cancer Res       Date:  2013       Impact factor: 6.242

5.  Identification of C(6) -ceramide-interacting proteins in D6P2T Schwannoma cells.

Authors:  Venkatesh Kota; Zdzislaw M Szulc; Hiroko Hama
Journal:  Proteomics       Date:  2012-07       Impact factor: 3.984

6.  DNA damage induces down-regulation of UDP-glucose ceramide glucosyltransferase, increases ceramide levels and triggers apoptosis in p53-deficient cancer cells.

Authors:  Teka-Ann S Haynes; Valery Filippov; Maria Filippova; Jun Yang; Kangling Zhang; Penelope J Duerksen-Hughes
Journal:  Biochim Biophys Acta       Date:  2012-02-11

7.  Regulation of autophagy and its associated cell death by "sphingolipid rheostat": reciprocal role of ceramide and sphingosine 1-phosphate in the mammalian target of rapamycin pathway.

Authors:  Makoto Taniguchi; Kazuyuki Kitatani; Tadakazu Kondo; Mayumi Hashimoto-Nishimura; Satoshi Asano; Akira Hayashi; Susumu Mitsutake; Yasuyuki Igarashi; Hisanori Umehara; Hiroyuki Takeya; Junzo Kigawa; Toshiro Okazaki
Journal:  J Biol Chem       Date:  2012-10-03       Impact factor: 5.157

8.  Retinoblastoma gene product as a downstream target for a ceramide-dependent pathway of growth arrest.

Authors:  G S Dbaibo; M Y Pushkareva; S Jayadev; J K Schwarz; J M Horowitz; L M Obeid; Y A Hannun
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

9.  Bcl-2 interrupts the ceramide-mediated pathway of cell death.

Authors:  J Zhang; N Alter; J C Reed; C Borner; L M Obeid; Y A Hannun
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

10.  Withanolide D induces apoptosis in leukemia by targeting the activation of neutral sphingomyelinase-ceramide cascade mediated by synergistic activation of c-Jun N-terminal kinase and p38 mitogen-activated protein kinase.

Authors:  Susmita Mondal; Chandan Mandal; Rajender Sangwan; Sarmila Chandra; Chitra Mandal
Journal:  Mol Cancer       Date:  2010-09-13       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.